Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Long-term Safety Study of Infliximab (Remicade)

ClinicalTrials.gov ID: NCT00261976

Public ClinicalTrials.gov record NCT00261976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 1:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Safety Follow-up of REMICADE (RESULTS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study evaluating the long-term safety of infliximab (Remicade)

Study identification

NCT ID
NCT00261976
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Centocor, Inc.
Industry
Enrollment
2,971 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2002
Primary completion
Feb 29, 2012
Completion
Feb 29, 2012
Last update posted
Mar 17, 2014

2002 – 2012

United States locations

U.S. sites
100
U.S. states
37
U.S. cities
100
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Huntsville Alabama — —
Not listed Montgomery Alabama — —
Not listed Paradise Valley Arizona — —
Not listed Phoenix Arizona — —
Not listed Tucson Arizona — —
Not listed Little Rock Arkansas — —
Not listed Anaheim California — —
Not listed Fresno California — —
Not listed Irvine California — —
Not listed Los Angeles California — —
Not listed Madera California — —
Not listed Orange California — —
Not listed Pasadena California — —
Not listed Rancho Mirage California — —
Not listed San Diego California — —
Not listed Santa Monica California — —
Not listed Stanford California — —
Not listed Torrance California — —
Not listed Denver Colorado — —
Not listed Hamden Connecticut — —
Not listed Hartford Connecticut — —
Not listed New Haven Connecticut — —
Not listed Waterbury Connecticut — —
Not listed Aventura Florida — —
Not listed Largo Florida — —
Not listed Ocala Florida — —
Not listed Orlando Florida — —
Not listed Palm Harbor Florida — —
Not listed Sarasota Florida — —
Not listed Tampa Florida — —
Not listed Alpharetta Georgia — —
Not listed Atlanta Georgia — —
Not listed Marietta Georgia — —
Not listed Coeur d'Alene Idaho — —
Not listed Chicago Illinois — —
Not listed Evanston Illinois — —
Not listed Gurnee Illinois — —
Not listed Maywood Illinois — —
Not listed Normal Illinois — —
Not listed Rockford Illinois — —
Not listed Springfield Illinois — —
Not listed Indianapolis Indiana — —
Not listed Iowa City Iowa — —
Not listed Overland Park Kansas — —
Not listed Wichita Kansas — —
Not listed Louisville Kentucky — —
Not listed Portland Maine — —
Not listed Baltimore Maryland — —
Not listed Greenbelt Maryland — —
Not listed Wheaton Maryland — —
Not listed Andover Massachusetts — —
Not listed Boston Massachusetts — —
Not listed Worcester Massachusetts — —
Not listed Ann Arbor Michigan — —
Not listed Detroti Michigan — —
Not listed East Lansing Michigan — —
Not listed Grand Rapids Michigan — —
Not listed Edina Minnesota — —
Not listed Fridley Minnesota — —
Not listed Jackson Mississippi — —
Not listed St Louis Missouri — —
Not listed Lincoln Nebraska — —
Not listed Reno Nevada — —
Not listed Voorhees Township New Jersey — —
Not listed Manhasset New York — —
Not listed New York New York — —
Not listed Rochester New York — —
Not listed Charlotte North Carolina — —
Not listed Durham North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Wilmington North Carolina — —
Not listed Winston-Salem North Carolina — —
Not listed Akron Ohio — —
Not listed Cincinnati Ohio — —
Not listed Cleveland Ohio — —
Not listed Columbus Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Lake Oswego Oregon — —
Not listed Portland Oregon — —
Not listed Bethlehem Pennsylvania — —
Not listed Lancaster Pennsylvania — —
Not listed Norristown Pennsylvania — —
Not listed Philadelphia Pennsylvan Pennsylvania — —
Not listed West Reading Pennsylvania — —
Not listed Willow Grove Pennsylvania — —
Not listed North Charleston South Carolina — —
Not listed Goodlettsville Tennessee — —
Not listed Nashville Tennessee — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Lubbock Texas — —
Not listed San Antonio Texas — —
Not listed Burlington Vermont — —
Not listed Salem Virginia — —
Not listed Bellevue Washington — —
Not listed Kirkland Washington — —
Not listed Seattle Washington — —
Not listed Spokane Washington — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00261976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2014 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00261976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →